Literature DB >> 21870864

Solvent interaction energy calculations on molecular dynamics trajectories: increasing the efficiency using systematic frame selection.

Markus A Lill1, Jared J Thompson.   

Abstract

End-point methods such as linear interaction energy (LIE) analysis, molecular mechanics generalized Born solvent-accessible surface (MM/GBSA), and solvent interaction energy (SIE) analysis have become popular techniques to calculate the free energy associated with protein-ligand binding. Such methods typically use molecular dynamics (MD) simulations to generate an ensemble of protein structures that encompasses the bound and unbound states. The energy evaluation method (LIE, MM/GBSA, or SIE) is subsequently used to calculate the energy of each member of the ensemble, thus providing an estimate of the average free energy difference between the bound and unbound states. The workflow requiring both MD simulation and energy calculation for each frame and each trajectory proves to be computationally expensive. In an attempt to reduce the high computational cost associated with end-point methods, we study several methods by which frames may be intelligently selected from the MD simulation including clustering and address the question of how the number of selected frames influences the accuracy of the SIE calculations.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21870864      PMCID: PMC3212856          DOI: 10.1021/ci200191m

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  37 in total

1.  Ligand-receptor docking with the Mining Minima optimizer.

Authors:  L David; R Luo; M K Gilson
Journal:  J Comput Aided Mol Des       Date:  2001-02       Impact factor: 3.686

2.  Enhanced docking with the mining minima optimizer: acceleration and side-chain flexibility.

Authors:  Visvaldas Kairys; Michael K Gilson
Journal:  J Comput Chem       Date:  2002-12       Impact factor: 3.376

3.  Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. Parameterization and validation.

Authors:  Araz Jakalian; David B Jack; Christopher I Bayly
Journal:  J Comput Chem       Date:  2002-12       Impact factor: 3.376

4.  A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations.

Authors:  Yong Duan; Chun Wu; Shibasish Chowdhury; Mathew C Lee; Guoming Xiong; Wei Zhang; Rong Yang; Piotr Cieplak; Ray Luo; Taisung Lee; James Caldwell; Junmei Wang; Peter Kollman
Journal:  J Comput Chem       Date:  2003-12       Impact factor: 3.376

5.  Development and testing of a general amber force field.

Authors:  Junmei Wang; Romain M Wolf; James W Caldwell; Peter A Kollman; David A Case
Journal:  J Comput Chem       Date:  2004-07-15       Impact factor: 3.376

6.  Assessing scoring functions for protein-ligand interactions.

Authors:  Philippe Ferrara; Holger Gohlke; Daniel J Price; Gerhard Klebe; Charles L Brooks
Journal:  J Med Chem       Date:  2004-06-03       Impact factor: 7.446

7.  Free energy, entropy, and induced fit in host-guest recognition: calculations with the second-generation mining minima algorithm.

Authors:  Chia-En Chang; Michael K Gilson
Journal:  J Am Chem Soc       Date:  2004-10-13       Impact factor: 15.419

8.  Design of novel, potent, noncovalent inhibitors of thrombin with nonbasic P-1 substructures: rapid structure-activity studies by solid-phase synthesis.

Authors:  W C Lumma; K M Witherup; T J Tucker; S F Brady; J T Sisko; A M Naylor-Olsen; S D Lewis; B J Lucas; J P Vacca
Journal:  J Med Chem       Date:  1998-03-26       Impact factor: 7.446

9.  A new method for predicting binding affinity in computer-aided drug design.

Authors:  J Aqvist; C Medina; J E Samuelsson
Journal:  Protein Eng       Date:  1994-03

10.  L-374,087, an efficacious, orally bioavailable, pyridinone acetamide thrombin inhibitor.

Authors:  P E Sanderson; K J Cutrona; B D Dorsey; D L Dyer; C M McDonough; A M Naylor-Olsen; I W Chen; Z Chen; J J Cook; S J Gardell; J A Krueger; S D Lewis; J H Lin; B J Lucas; E A Lyle; J J Lynch; M T Stranieri; K Vastag; J A Shafer; J P Vacca
Journal:  Bioorg Med Chem Lett       Date:  1998-04-07       Impact factor: 2.823

View more
  7 in total

1.  Exhaustive search and solvated interaction energy (SIE) for virtual screening and affinity prediction.

Authors:  Traian Sulea; Hervé Hogues; Enrico O Purisima
Journal:  J Comput Aided Mol Des       Date:  2011-12-25       Impact factor: 3.686

2.  Assessment of mutations on RBD in the Spike protein of SARS-CoV-2 Alpha, Delta and Omicron variants.

Authors:  Clauber Henrique Souza da Costa; Camila Auad Beltrão de Freitas; Cláudio Nahum Alves; Jerônimo Lameira
Journal:  Sci Rep       Date:  2022-05-20       Impact factor: 4.996

3.  Molecular recognition in a diverse set of protein-ligand interactions studied with molecular dynamics simulations and end-point free energy calculations.

Authors:  Bo Wang; Liwei Li; Thomas D Hurley; Samy O Meroueh
Journal:  J Chem Inf Model       Date:  2013-10-08       Impact factor: 4.956

4.  Variability in docking success rates due to dataset preparation.

Authors:  Christopher R Corbeil; Christopher I Williams; Paul Labute
Journal:  J Comput Aided Mol Des       Date:  2012-05-08       Impact factor: 3.686

5.  Structure-Based Virtual Screening, Molecular Dynamics and Binding Free Energy Calculations of Hit Candidates as ALK-5 Inhibitors.

Authors:  Sheila C Araujo; Vinicius G Maltarollo; Michell O Almeida; Leonardo L G Ferreira; Adriano D Andricopulo; Kathia M Honorio
Journal:  Molecules       Date:  2020-01-09       Impact factor: 4.411

6.  Structural, energetic and lipophilic analysis of SARS-CoV-2 non-structural protein 9 (NSP9).

Authors:  Jéssica de O Araújo; Silvana Pinheiro; William J Zamora; Cláudio Nahum Alves; Jerônimo Lameira; Anderson H Lima
Journal:  Sci Rep       Date:  2021-11-26       Impact factor: 4.379

7.  Ponatinib is a pan-BCR-ABL kinase inhibitor: MD simulations and SIE study.

Authors:  Karunakar Tanneeru; Lalitha Guruprasad
Journal:  PLoS One       Date:  2013-11-13       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.